Transforming the management of dermatologic cancers and other dermatologic diseases with high unmet need May 10, 2021 DISCLAIMERS 2 FORWARD - LOOKING STATEMENTS The information in this press release contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are ...

Transforming the management of dermatologic cancers and other dermatologic diseases with high unmet need May 10, 2021 DISCLAIMERS 2 FORWARD - LOOKING STATEMENTS The information in this press release contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are ...

Castle Biosciences, Inc. (NASDAQ:CSTL) Q1 2021 Earnings Conference Call May 10, 2021 4:30 PM ET Company Participants Camilla Zuckero - Executive Director, Investor Relations & Corporate Communications Derek Maetzold - Founder, President, and Chief Executive Officer Frank Stokes - Chief Financial Officer Conference Call Participants Thomas Flaten - Lake Street Capital Markets. Catherine Schulte - Baird Max Masucci - Canaccord Genuity Puneet Souda - SVB Leerink Operator Good afternoon, and welcome to Castle B ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-38984 CASTLE BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) Del ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-38984 Delaware 77-0701774 (State or other jurisdiction of incorporation or organization)(I.R.S. ...

Transforming the management of dermatologic cancers March 8, 2021 DISCLAIMERS FORWARD - LOOKING STATEMENTS The information in this presentation contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concerning the effects of th ...

Castle Biosciences, Inc (NASDAQ:CSTL) Q4 2020 Earnings Conference Call March 8, 2021 4:30 PM ET Company Participants Derek Maetzold - Founder, President, and Chief Executive Officer Frank Stokes - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Paul Knight - KeyBanc Sung Nam - BTIG Catherine Schulte - Baird Max Masucci - Canaccord Genuity Operator Good afternoon, and welcome to Castle Biosciences' Fourth Quarter and Full Year 2020 Conference Call. As a reminder, today's ...

The Skin Cancer Diagnostics Company COMPANY PRESENTATION January 2021 NASDAQ: CSTL DISCLAIMERS 2 › Forward-Looking Statements › The information in this presentation contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concern ...

The Skin Cancer Diagnostics Company COMPANY PRESENTATION November 9, 2020 NASDAQ: CSTL DISCLAIMERS 2 › Forward-Looking Statements › The information in this presentation contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements con ...

Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2020 Earnings Conference Call November 9, 2020 4:30 PM ET Company Participants Frank Stokes - Chief Financial Officer Derek Maetzold - Founder, President & Chief Executive Officer Conference Call Participants Max Masucci - Canaccord Genuity Sung Ji Nam - BTIG Puneet Souda - SVB Leerink Operator Good afternoon and welcome to the Castle Biosciences Third Quarter 2020 Conference Call. As a reminder, today's call is being recorded. We will begin today's call with openin ...